EGFR and non-small cell lung carcinoma: In another study of NSCLC, KRIBB11 is shown to reduce drug resistance potentially associated with EMT by downregulating EMT-associated proteins, such as N-cadherin and vimentin, and EGFR, along with other key signaling molecules (Shibue and Weinberg, 2017; Lee et al., 2021).